The pro-apoptotic JNK signaling pathway was therefore considered a potential target for cancer therapy, which has been documented as one of the major apoptosis mediators for CML cells (10). Here, MAPK8 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.